Regarding MCM9, 2 families carried biallelic genetic variants, including a LLS patient with premature ovarian failure (POF) and a familial MMR-proficient CRC patient, and heterozygote variants were found in 12 patients. This evidence concerns the gene MCM9 and colorectal carcinoma.